Pulse Biosciences, Inc. (PLSE) SEC Filings — 2024

Filings

• Pulse Biosciences Files 8-K — 8-K · Dec 26, 2024
• Pulse Biosciences Announces Executive and Board Changes — 8-K · Dec 6, 2024
• Pulse Biosciences Relocates Executive Offices to Miami — 8-K · Nov 26, 2024
• Pulse Biosciences Files 8-K — 8-K · Oct 31, 2024
• Pulse Biosciences Q3 2024: Net Loss and Operating Expenses Detailed — 10-Q · Oct 30, 2024
• Pulse Biosciences Q2 2024: Revenue Flat, Expenses Rise — 10-Q · Aug 19, 2024
• Pulse Biosciences Acquires Lumina Health for $10M — 8-K · Aug 12, 2024
• Pulse Biosciences Appoints New CFO, Grants Stock Options — 8-K · Aug 8, 2024
• Pulse Biosciences Files 8-K on Material Agreement — 8-K · Jul 15, 2024
• Duggan Amends Pulse Biosciences Stake — SC 13D/A · Jul 8, 2024
• Pulse Biosciences Merges with Lumena Pharmaceuticals — 8-K · Jul 8, 2024
• Pulse Biosciences Files 8-K — 8-K · Jul 3, 2024
• Pulse Biosciences Files 8-K — 8-K · Jun 28, 2024
• Pulse Biosciences Appoints New CFO, Elects Directors — 8-K · Jun 7, 2024
• Pulse Biosciences Files 8-K — 8-K · Jun 4, 2024
• Pulse Biosciences Files 8-K Report — 8-K · May 20, 2024
• Pulse Biosciences Appoints New CFO — 8-K · May 15, 2024
• Pulse Biosciences Closes $20M Public Offering — 8-K · May 9, 2024
• Pulse Biosciences, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 7, 2024
• Pulse Biosciences Files 8-K Report — 8-K · May 2, 2024
• Pulse Biosciences, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 23, 2024
• Pulse Biosciences, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024
• Pulse Biosciences Sells ElectroBlate Subsidiary — 8-K · Mar 11, 2024
• Pulse Biosciences Files Standard 8-K on Feb 14 — 8-K · Feb 14, 2024
• Pulse Biosciences Files 8-K for Regulation FD Disclosure — 8-K · Jan 9, 2024
• Pulse Biosciences Files Routine 8-K on Jan 2, 2024 — 8-K · Jan 2, 2024